vimarsana.com
Home
Live Updates
Sandoz To Launch Tyruko Biosimilar For Multiple Sclerosis In
Sandoz To Launch Tyruko Biosimilar For Multiple Sclerosis In
Sandoz To Launch Tyruko Biosimilar For Multiple Sclerosis In Germany On Feb. 1
(RTTNews) - Sandoz (SDZNY), a maker of generic and biosimilar medicines, announced Wednesday the launch of Tyruko (natalizumab) in Germany from Fe...
Related Keywords
Germany ,
Rebecca Guntern ,
Polpharma Biologics ,
European Commission ,
More Such Health News ,
President Europe ,